Vitae Pharmaceuticals, Inc.

Allergan PLC Chairman, President and CEO Brent Saunders made it clear that he thinks the company is on the right track with financial performance that backs up his view, but a strategic review is ong

IN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over

Impact Biomedicines has closed a structured financing for up to $90m – just two weeks after launching with $22.5m in venture capital – that will support commercialization of its JAK2 inhibitor fedra

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in